NursesPrint Go Premium
Medical Surgical Nursing

ATI LPN

Medical Surgical Nursing

Difficulty: Medium Average Score: 76% Practice

A pharmaceutical company is designing agents to treat the recurrent bronchospasm of bronchial asthma. Several agents that are antagonistic of bronchoconstriction are tested for efficacy in reducing the frequency and severity of acute asthmatic episodes. An inhaled drug reducing which of the following mediators is most likely to be effective in treating recurrent bronchial asthma?

Related Questions

View all